Pacific Biosciences of California, Inc. (PACB)
2.54
+0.03
(+1.20%)
USD |
NASDAQ |
Oct 02, 16:00
2.54
0.00 (0.00%)
After-Hours: 20:00
Pacific Biosciences of California Profit Margin (Quarterly) : -114.7% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -114.7% |
| March 31, 2026 | -22.26% |
| December 31, 2025 | -90.43% |
| September 30, 2025 | -98.85% |
| June 30, 2025 | -105.4% |
| March 31, 2025 | -1.15K% |
| December 31, 2024 | 9.10% |
| September 30, 2024 | -151.9% |
| June 30, 2024 | -481.3% |
| March 31, 2024 | -201.4% |
| December 31, 2023 | -140.5% |
| September 30, 2023 | -120.1% |
| June 30, 2023 | -146.8% |
| March 31, 2023 | -226.3% |
| December 31, 2022 | -308.5% |
| September 30, 2022 | -238.2% |
| June 30, 2022 | -201.3% |
| March 31, 2022 | -245.7% |
| December 31, 2021 | -192.5% |
| September 30, 2021 | 47.42% |
| June 30, 2021 | -133.9% |
| March 31, 2021 | -301.5% |
| December 31, 2020 | |
| September 30, 2020 | -124.2% |
| June 30, 2020 | -135.2% |
| Date | Value |
|---|---|
| March 31, 2020 | 8.09% |
| December 31, 2019 | -0.33% |
| September 30, 2019 | -132.9% |
| June 30, 2019 | -99.90% |
| March 31, 2019 | -184.6% |
| December 31, 2018 | -157.7% |
| September 30, 2018 | -137.9% |
| June 30, 2018 | -104.5% |
| March 31, 2018 | -124.9% |
| December 31, 2017 | -83.26% |
| September 30, 2017 | -93.53% |
| June 30, 2017 | -127.2% |
| March 31, 2017 | -95.79% |
| December 31, 2016 | -73.98% |
| September 30, 2016 | -69.65% |
| June 30, 2016 | -89.16% |
| March 31, 2016 | -101.2% |
| December 31, 2015 | -3.88% |
| September 30, 2015 | 13.08% |
| June 30, 2015 | -47.86% |
| March 31, 2015 | -114.3% |
| December 31, 2014 | -112.3% |
| September 30, 2014 | -44.43% |
| June 30, 2014 | -167.5% |
| March 31, 2014 | -162.2% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Illumina, Inc. | 17.83% |
| Danaher Corp. | 13.89% |
| Repligen Corp. | 2.45% |
| Thermo Fisher Scientific, Inc. | 14.52% |
| Agilent Technologies, Inc. | 19.28% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -911.4% |
| Return on Assets | -16.64% |
| Return on Invested Capital | -18.33% |
| Gross Profit Margin (Quarterly) | 30.26% |
| Operating Margin (Quarterly) | -114.4% |
| Return on Net Operating Assets | -27.13% |